Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Antigen-antibody Complex
7%
Antiviral Treatment
5%
Capsid
11%
Chronic Hepatitis B
27%
Chronic Hepatitis B Patients
22%
Chronic Hepatitis B Virus Infection
8%
Circulating Tumor DNA (ctDNA)
13%
Covalently Closed Circular DNA
17%
COVID-19
9%
Desflurane
5%
Enterovirus 71 (EV71)
7%
Enterovirus 71 Infection
5%
Fluorescence in Situ Hybridization
6%
Gene Expression
8%
H7N9 Influenza Virus
6%
H7N9 Virus
7%
HepAD38
6%
Hepatitis
6%
Hepatitis B Surface Antigen (HBsAg)
31%
Hepatitis B Virus
63%
Hepatitis B Virus DNA
11%
Hepatitis B Virus Infection
7%
Hepatitis B Virus Replication
12%
Hepatitis B Virus RNA
16%
Hepatitis C Virus
6%
In Situ Analysis
5%
In Situ Assay
6%
In Situ Hybridization
20%
Interferon-α (IFN-α)
21%
Liver Fibrosis
7%
Macrophages
6%
MicroRNA
13%
MicroRNA Profile
5%
Mouse Model
7%
Myeloid Differentiation Factor 88 (MyD88)
5%
Nuclear factor-κB
5%
Pathobiology
6%
Pregenomic RNA (pgRNA)
10%
Quantitative PCR
9%
R292K
5%
Recombinant
11%
RNA-DNA
7%
Rupintrivir
5%
Severe Cases
6%
Sustained Virological Response
6%
Viral Shedding
5%
Virion
6%
Virus
14%
Virus nucleic Acid
6%
Virus Polymerase
5%
Immunology and Microbiology
Blood Plasma
6%
Capsid
12%
Cell Culture
7%
COVID-19
11%
DNA RNA Hybridization
7%
DNA Virus
13%
Fluorescence in Situ Hybridization
6%
Gene Expression
7%
HBsAg
25%
Hepatitis B
62%
Hepatitis B Antigen
25%
Hepatitis B Virus
100%
Hepatitis C Virus
6%
Hepatoma Cell
5%
In Situ Hybridization
8%
In Vitro
6%
Infection
23%
Infectious Agent
12%
Influenza
8%
Influenza A Virus (H7N9)
11%
Interferon
17%
Interferon Alfa
6%
Lineage
6%
Macrophage
6%
Membrane Antigen
9%
Metagenomics
5%
Mouse Model
7%
Promoter Region
5%
Ribonucleic Acid
17%
Severe Acute Respiratory Syndrome Coronavirus 2
6%
Viral Replication
16%
Viral Shedding
5%
Virion
7%
Virus
19%
Virus Antigen
5%